A healthcare worker prepares to administer a COVAXIN vaccine, developed by Indian company Bharat Biotech, at a private hospital in New Delhi, India, Tuesday, March 2, 2021. India is expanding its coronavirus vaccination drive beyond health care and front-line workers, offering the shots to older people and those with medical conditions that put them at risk. (AP Photo/Altaf Qadri) (AP)
- This entails that the beneficiaries will not be required to sign a consent form to take the indigenous coronavirus vaccine if the expert panel recommendation is accepted by the country’s top drugs regulator
-
The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended granting emergency use authorisation to Bharat Biotech’s indigenously developed Covaxin while removing the condition for the vaccine to be administered in ‘clinical trial mode’.With thanks -mint
Follow us on Facebook http://facebook.com/HamaraGhaziabad
Follow us on Twitter http://twitter.com/HamaraGhaziabad